Roivant Sciences ROIV Balance Sheet Statement
| TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | TTM Q4 '24 | ||
|---|---|---|---|---|---|---|
| $1.42B+1,411% | $91.94M-7.2% | $102.19M-17.2% | $94.79M-98.3% | $93.95M-48.6% | ||
| $2.87B— | $3.05B— | $3.15B— | $3.26B— | —— | ||
| $5.17B+3.3% | $4.66B-13.1% | $4.51B-22.2% | $4.62B-23.1% | $5B-25.7% | ||
| $11.99M-0.6% | $13.45M-0.9% | $25.67M+87.7% | $14.87M-16.7% | $12.06M-21.3% | ||
| $5.71B+5.0% | $5.23B-9.8% | $5.06B-18.4% | $5.03B-22.5% | $5.44B-24.7% | ||
| $18M-24.0% | $13.29M-43.9% | $15.06M-40.0% | $11.55M-58.4% | $23.69M+68.9% | ||
| —— | —— | —— | —— | $1.17M-72.0% | ||
| $281.24M+88.2% | $151.96M+7.4% | $133.86M-75.9% | $113.87M-47.1% | $149.41M-44.0% | ||
| $416.28M+66.7% | $251.14M-2.0% | $257.14M-58.9% | $216.7M-64.0% | $249.74M-67.7% | ||
| $0— | $7B0.0% | $7B0.0% | $7B0.0% | $0— | ||
| -$501.81M-532% | -$695M-251% | -$429.11M-208% | -$315.59M-147% | $116.06M-79.9% | ||
| $4.53B-3.4% | $4.27B-17.7% | $4.36B-15.3% | $4.35B-20.0% | $4.69B-21.5% | ||
| $5.71B+5.0% | $5.23B-9.8% | $5.06B-18.4% | $5.03B-22.5% | $5.44B-24.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Roivant Sciences's total assets?
- Roivant Sciences (ROIV) holds $5.7B in total assets, up 5.0% year over year.
- How much debt does Roivant Sciences have?
- Roivant Sciences carries $107.4M in total debt against $4.5B of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Roivant Sciences have?
- Roivant Sciences holds $1.4B in cash and equivalents.
- Can Roivant Sciences cover its short-term obligations?
- Its current ratio is 18.37 — current assets exceed current liabilities.
- Where does Roivant Sciences's balance sheet data come from?
- Every line is extracted from Roivant Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
